Stay updated on Belvarafenib in NRAS-Mutant Melanoma Clinical Trial
Sign up to get notified when there's something new on the Belvarafenib in NRAS-Mutant Melanoma Clinical Trial page.

Latest updates to the Belvarafenib in NRAS-Mutant Melanoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new page revision entry v3.4.2 was added, and an existing funding-notice and the older v3.4.1 revision were removed from the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check21 days agoChange DetectedNotice banner about government funding was added and the history now includes a new revision entry (v3.4.1) dated 2026-02-02. These are administrative updates and do not modify core trial data or the user-facing functionality of the page.SummaryDifference0.7%

- Check28 days agoChange DetectedUI updates include a Show glossary option and color-coded indicators for additions and deletions, along with a revised version note (Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check35 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4; a minor administrative update.SummaryDifference0.1%

- Check50 days agoChange DetectedOn 2025-12-31, new History entries were added for Contacts/Locations and Study Status; the version count shows 43 on 2025-12-30, and an entry dated 2025-09-30 was removed.SummaryDifference0.3%

- Check64 days agoChange DetectedAdded Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer. No study data or core functionality was affected.SummaryDifference0.1%

Stay in the know with updates to Belvarafenib in NRAS-Mutant Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belvarafenib in NRAS-Mutant Melanoma Clinical Trial page.